Skip to the content
Kure Cellslogo darklogo light
  • Home
  • About Us
  • Technology
  • Pipeline
  • News
  • Partner With Us
Kure Cells
  • Home
  • About Us
  • Technology
  • Pipeline
  • News
  • Partner With Us
Home2025May
KureCells

ISCT Top Scoring Abstract Award for UF-Kure19 Ph1 trial

rkjamvi@gmail.com
May 17, 2025
rkjamvi@gmail.com

principal scientist

Kure Cells closed pre-Series A funding round led by Waed Ventures (Aramco) alongside NantBio, US93 and Qomel

rkjamvi@gmail.com
October 23, 2025

UF-Kure19 granted RMAT designation by FDA based on promising efficacy for LBCL and follicular lymphoma and rapid manufacturing

rkjamvi@gmail.com
October 17, 2025
Categories
KureCells
Follow us
w
We believe in open projects
View more

Disclaimer: Investigational products; safety and efficacy not yet established.

Privacy Policy

Expanded Access Policy

© 2025 kurecells, All Rights Reserved

Back to top Drag